Long-term outcome following heart transplantation: current perspective

Area of Science:

• Cardiology
• Transplantation Medicine
• Medical Devices

Background:

• Heart transplantation is the primary treatment for end-stage heart failure (HF).
• Current survival and functional status post-transplant are superior to medical therapy.
• Challenges include transplant rejection and immunosuppression side effects like infection, malignancy, and renal issues.

Purpose of the Study:

• To evaluate the current standing of heart transplantation in HF treatment.
• To compare heart transplantation with emerging mechanical circulatory support (MCS) devices.
• To discuss the limitations and future potential of both treatment modalities.

Main Methods:

• Review of current literature on heart transplantation outcomes.
• Analysis of survival rates and functional status in HF patients.
• Assessment of complications associated with transplantation and immunosuppression.
• Evaluation of data on mechanical circulatory support devices.

Main Results:

• Heart transplantation demonstrates excellent survival and functional outcomes compared to medical management.
• Acute and chronic rejection, alongside immunosuppression sequelae, impede optimal results.
• Mechanical circulatory support devices show improving outcomes and potential competitiveness for select HF patients.

Conclusions:

• Heart transplantation remains a leading therapy for end-stage HF.
• Immunosuppression complications and rejection are significant challenges.
• Mechanical circulatory support offers a promising alternative, but long-term efficacy requires further investigation.